Advertisement

Advances in Genetic Prediction and Diagnosis

  • Marcus Pembrey
Part of the NATO ASI Series book series (NSSA, volume 161)

Summary

Recombinant DNA technology has revolutionized the study of genetic influences in disease. There now exists a low resolution linkage map of DNA markers covering the whole human genome and the loci involved in most common monogenic disorders have been mapped. This permits first trimester prenatal diagnosis and carrier detection within most affected families using the generalized strategy of gene tracking. It has also allowed the cloning of the dystrophin gene (the site of the Duchenne muscular dystrophy mutation) and other genes by “reverse genetics”. Direct detection of the mutation causing a monogenic disease is becoming easier; A technique that has assisted in this is the million fold or more amplification of a known target DNA sequence by the polymerase chain reaction. DNA amplification facilitates the elucidation of protein sequence variations in populations that represent susceptibility genes to common multifactorial disease. Much of the heritability of insulin-dependent diabetes mellitus (IDDM) has now been shown to reside in the identity of amino acid 57 of the HLA class II molecule the DQB-chain. Aspartic acid in this position appears to protect against IDDM. It is hoped that elucidation of genetic influences in disorders of complex etiology will help clarify the non-genetic influences and allow people to maximize their chance of good health.

Keywords

Sickle Cell Anemia Prenatal Diagnosis Duchenne Muscular Dystrophy Prenatal Test Gene Tracking 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    C.O. Carter. Monogenic disorders. J. Med. Genet. 14: 316–320 (1977).PubMedCrossRefGoogle Scholar
  2. 2.
    R.K. Saiki, T.L. Bugawan, G.T. Horn, K.B. Mullis and H.A. Erlich. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324: 163–168 (1986).PubMedCrossRefGoogle Scholar
  3. 3.
    H.A. Erlich, D.H. Gelfand and R.K. Saiki. Specific DNA amplification. Nature 331: 461 (1988).CrossRefGoogle Scholar
  4. 4.
    H. Donis-Keller, P. Green, C. Helms, S. Cartinhour, B. Weiffenbach, K. Stephens et al. Genetic linkage map of the human genome. Cell 51: 319–337 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    E.M. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    S.M. Forrest, G.S. Cross, A. Speer, D. Gardner-Medwin, J. Burns, and K.E. Davies. Preferential deletion of oxons in Duchenne and Becker muscular dystrophies. Nature 329: 638–640 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    A. Cao, M. Piratsu and C. Rosatelli. The prenatal diagnosis of thalassaemia. Br. J. Haematol. 63: 215–220 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    J.C. Chang and Y.W. Kan. A sensitive new prenatal test for sickle cell anemia. N. Engl. J. Med. 307: 30–32 (1982).PubMedCrossRefGoogle Scholar
  9. 9.
    V.J. Kidd, R.B. Wallace, K. Itakura, and S.L.C. Woo. Alpha 1 antitrypsin deficiency detection by direct analysis of the mutation in the gene. Nature 304: 230–234 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    R.M. Winter, K. Harper, E. Goldman, R.S. Mibasham, R.C. Warren, C.H. Rodeck, R.J.A. Penketh, R.H.T. Ward, R.M. Hardisty and M.E. Pembrey. First trimester prenatal diagnosis and detection of carriers of haemophilia A using the linked DNA probe DX13. Br. Med. J. 291: 765769 (1985).Google Scholar
  11. 11.
    S.H. Embury, S.J. Scharf, R.K. Saiki, M.A. Gholson, M. Golbus, N. Arnheim and H.A. Erlich. Rapid prenatal diagnosis of sickle cell anemia by a new method of DNA analysis. N. Engl. J. Med. 316: 656–661 (1987).PubMedCrossRefGoogle Scholar
  12. 12.
    R. Penketh and A. McLaren. Prospects for prenatal diagnosis during preimplantation human development. In Clinical Obstetrics and Gynaecology; Fetal Diagnosis of Genetic Defects. Vol. 1 no. 3, pp 747–765. C.H. Rodeck (ed.) Bailliere Tindall, London (1987).Google Scholar
  13. 13.
    C.C. Impraim, R.K. Saiki, H.A. Erlich and R.L. Tepliltz. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissues by enzymatic amplification and hybridization with sequence-specific oligonucleotides. Biochem. Biophys. Res. Commun. 142: 710–716 (1987).PubMedCrossRefGoogle Scholar
  14. 14.
    É.P. Hoffman, R.H. Brown Jr. and L.M. Kunkel. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919–928 (1987).PubMedCrossRefGoogle Scholar
  15. 15.
    J.A. Todd, J.I. Bell and H.O. McDevitt. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604 (1987).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Marcus Pembrey
    • 1
  1. 1.Mothercare Department of Pediatric Genetics, Institute of Child HealthUniversity of LondonLondonUK

Personalised recommendations